Pristine's Option Play of the Week - 5/27/2009 - Email from Pristine.com

OPTION PLAY OF THE WEEK

If you have trouble viewing this email, go to: http://www.pristine.com/services/WeeklyOption/

Attend a FREE Workshop Click Here For More Info

This service is updated every Wednesday at:
http://www.pristine.com/services/WeeklyOption/
By Frank Kneipher, Senior Pristine Option Strategist

Chart Courtesy of Mastertrader.com

Industry: MED - DRUGS Closing Price: 19.90 P/E: 12.59 Avg. Vol.: 13,473K

Company Profile: Bristol-Myers Squibb Company engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of pharmaceuticals and nutritional products worldwide. It operates in two segments, Pharmaceuticals and Nutritionals. The Pharmaceuticals segment offers cardiovascular products, virology products, oncology products and other psychiatric disorder products. It sells its pharmaceutical products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, and pharmacies. The Nutritionals segment manufactures, markets, distributes, and sells infant formulas and other nutritional products comprising ENFAMIL products that contain nutrients. The company is also developing various compounds, which are in phase III clinical trials.

Objective: While looking for BMY to trade near its recent range, we will use an Income Stragegy with consideration for additional Accumulated Income.

Trade: BUY the SEP 20 CALLS and SELL the JUN 20 CALLS (Calendar Spread) for a Debit of at or near .70

Entry Target: BMY between 19.50 and 20.50 with Initial RISK MANAGEMENT Alerts at 19.20 and 20.80

People who read this article also subscribe to:
The Pristine Swing Trader, Pristine Swing Trader Lite, Pristine Option Strategy Newsletter

May 27, 2009
Past Issues - Print Version

Frank Kneipher

fk@pristine.com

Pristine Seminars
Click Here

Pristine ESP™
Click Here

Please keep in mind that all comments made by Pristine instructors and representatives are for educational purposes only and should not be construed as investment advice regarding the purchase or sale of securities, options, futures or any other financial instrument of any kind. Consult with your investment advisor before making an investment decision regarding any securities mentioned herein. Pristine instructors and representatives assume no responsibility for your trading and investment results.

Information for the stock observations was obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. The author as well as other Pristine employees, representatives and "affiliated" individuals may have a position or effect transactions in the securities herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

There is a very high degree of risk involved in any type of trading. Option and Futures trading is not suitable for all investors. Past results are not indicative of future returns. Pristine Capital Holdings, Inc., its subsidiaries and all "affiliated" individuals assume no responsibilities for your trading and investment results.

Pristine Capital Holdings, Inc.
7-11 South Broadway, Suite 210
White Plains, NY 10601
1-914-682-7613
Privacy Policy

COPYING AND OR ELECTRONIC TRANSMISSION OF THIS DOCUMENT WITHOUT THE WRITTEN CONSENT OF PRISTINE.COM IS A VIOLATION OF THE COPYRIGHT LAW.

---

You are currently subscribed to pristine as: david.m.halsey@gmail.com.

To unsubscribe click here: http://lyris.pristine.com/u?id=339967.fa8383666e4ac888673c7c6cd9cee152&n=T&l=pristine&o=141165

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-141165-339967.fa8383666e4ac888673c7c6cd9cee152@lyris.pristine.com